# Developmental Funds

> **NIH NIH P30** · DUKE UNIVERSITY · 2020 · $764,839

## Abstract

ABSTRACT – DEVELOPMENTAL FUNDS
 Duke Cancer Institute (DCI) Developmental Funds are instrumental to the DCI strategic research priorities
and provide resources to augment its Research Programs and Strategic Initiatives. In the current grant cycle,
DCI Developmental Funds, comprised of CCSG, institutional and philanthropic funds, have supported
collaborative, translational and novel high-impact pilot projects, recruitment of new investigators, and emerging
technologies that promote innovative new research of DCI members.
 The DCI supports multiple Pilot Grant Programs, including one which alternatively emphasizes collaborative
projects (intra-programmatic, inter-programmatic, population science) and translational projects (laboratory
discoveries into diagnostic, prognostic, or therapeutic applications), solicited through a “Request for Applications”
(RFA) twice each year. Additionally, DCI has targeted Pilot Grant Programs each year focused on strategic
topics, which are supported by multiple sources, including institutional and philanthropic funds. The strategic
areas of focus in the current funding period are: i) Cancer Control; ii) Cancer and the Environment; iii) Supportive
Care and Survivorship; iv) Comparative Oncology (an external collaboration with the College of Veterinary
Medicine at NC State University); v) Solid Tumor Brain Metastasis; vi) BRCA-associated cancers; and vii)
collaboration between cancer and engineering research. Faculty recruitment that represents a strategic
investment as outlined by the DCI strategic plan and DCI senior leaders are eligible for Developmental Funds
as part of their initial recruitment package, or within three years of their faculty appointment. The recruitment
funds are made available at any time throughout the year to maintain optimal flexibility in faculty recruitment.
Developmental Funds are also available through solicitations offered twice per year for support of a new service
line, creation and implementation of a new technique, or a technology investment that enhances existing shared
resource services and expands the research tools of DCI investigators.
 All applications for DCI Developmental Funds are reviewed by the Scientific Review Committee (SRC) or the
Shared Resource Oversight Committee (SROC). The DCI Steering Committee is charged with strategic
oversight of the DCI Developmental Funds. The final funding decisions are based on assessment of availability
of funds and prioritization of strategic investments, with approval by the DCI Executive Director.
 During this funding period, DCI Developmental Funds were used to support pilot and collaborative projects,
recruitment of faculty, and shared resource investment. The $2.9M of CCSG Developmental Funds were
augmented by additional $29.4M of institutional/philanthropic funds in all three categories. In the next funding
period, CCSG investments will continue to be augmented by institutional and philanthropic funds to advance DCI
scientific disc...

## Key facts

- **NIH application ID:** 9853612
- **Project number:** 2P30CA014236-46
- **Recipient organization:** DUKE UNIVERSITY
- **Principal Investigator:** Michael B Kastan
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $764,839
- **Award type:** 2
- **Project period:** — → —

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9853612

## Citation

> US National Institutes of Health, RePORTER application 9853612, Developmental Funds (2P30CA014236-46). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/9853612. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*